Donald L. Drakeman
Donald Lee Drakeman is an American entrepreneur, venture capitalist, business executive, academic, and scholar based in South Carolina.
He has since 2007 been a venture partner in Advent Venture Partners, a venture capital firm based in London, in connection with which he is a member of the firm's life sciences Team.[1] At the same time he is a Distinguished Research Professor in the Center for Citizenship and Constitutional Government at the University of Notre Dame[2] as well as a Fellow in Health Management of the Judge Business School at Cambridge University,[3] where he is a member of the Operations and Technology Management Subject Group and associated with the Cambridge Centre for Health Leadership & Enterprise.[4] He is in addition the Chairman of the advisory council of the James Madison Program in American Ideals and Institutions at Princeton University, where he was for many years a member of the faculty and taught lecture courses and seminars on civil liberties and the United States Constitution.[5][6]
His book Church, State, and Original Intent, which concerns the establishment clause of the First Amendment to the United States Constitution, was published by Cambridge University Press in 2010.[7][8][9][10][11] In 2015 Palgrave Macmillan published Why We Need the Humanities, which focuses on the relation of the humanities to the life sciences and to civil liberties.[12][13] In 2021 Cambridge University Press published The Hollow Core of Constitutional Theory: Why We Need the Framers, which defends the idea that the intentions of the Framers ought to have a central role in constitutional interpretation.[14] He is also one of the authors of From Breakthrough to Blockbuster: The Business of Biotechnology, which was published in 2022 by Oxford University Press.[15][16][17]
He was educated at Dartmouth College (AB magna cum laude),[18][19] Columbia Law School (JD Harlan Fiske Stone Scholar),[20] and Princeton University (MA, PhD in Religion).[21]
A resident of Montclair, New Jersey, he was appointed in 1994 as chair of the township's zoning board of adjustment.[22]
In the early stages of his career he worked as an attorney at Milbank, Tweed, Hadley & McCloy and was the vice-president of the Essex Chemical Corporation. He is best known as the co-founder of two biotechnology companies, Medarex Inc. and Genmab A/S, both of which develop drugs used in monoclonal antibody therapy.[23] During his tenure as the founding CEO of Medarex, the company raised more than a billion dollars, entered into alliances with many other pharmaceutical companies, and spun off Genmab, which subsequently completed the largest biotechnology IPO in the history of European capital markets up to the time of the offering.[3] He was an Ernst & Young Entrepreneur of the Year in 2005.[24]
He serves as a Trustee of Drew University,[25] a Visitor of Ralston College,[26] a member of the Board of Advisors of the Rutgers Business School,[27] and formerly served as a Trustee of the Woodrow Wilson National Fellowship Foundation and of the University of Charleston.[21] He is also a member of the editorial board of the journal mAbs.[28] He was formerly the Chairman of the New Jersey Commission on Science and Technology,[29][30] and has served on the boards of several companies, including Oxford Glycosciences, IDM-Pharma, and Mannkind. He continues to be a Director of Zymeworks Inc.[31] He is in addition a Fellow of the Royal Society of Biology, the Royal Historical Society, and of the Burgon Society.[32][33][34]
References
[edit]- ^ "Don Drakeman". Archived from the original on November 7, 2011. Retrieved 2011-11-10.
- ^ "Donald Drakeman". Center for Citizenship & Constitutional Government. University of Notre Dame. Retrieved June 23, 2024.
- ^ a b "Don Drakeman".
- ^ "Management Science - Subject Groups - Faculty & Research - Cambridge Judge Business School". Archived from the original on December 15, 2010. Retrieved 2011-01-12.
- ^ James Madison Program Archived September 17, 2016, at the Wayback Machine. Web.princeton.edu. Retrieved on November 10, 2011.
- ^ Xueqin, Jiang. (2010-06-13) Speakers See Threats to the Concept of Shared Governance – Faculty – The Chronicle of Higher Education. Chronicle.com. Retrieved on November 10, 2011.
- ^ Church, State, and Original Intent – Academic and Professional Books – Cambridge University Press. Cambridge.org. Retrieved on November 10, 2011.
- ^ "Sign In". Archived from the original on July 15, 2012.
- ^ Robes And Vestments | The New Republic. Tnr.com. Retrieved on November 10, 2011.
- ^ Church, State, And Original Intent Archived March 17, 2012, at the Wayback Machine. Bsos.umd.edu. Retrieved on November 10, 2011.
- ^ http://web.princeton.edu/sites/jmadison/calendar/documents/Flyer%202010%201008%20Drakeman%20Book%20Panel.pdf Archived March 10, 2012, at the Wayback Machine [bare URL PDF]
- ^ Drakeman, Donald (2016). Why We Need the Humanities – Life Science, Law and – Donald Drakeman – Palgrave Macmillan. doi:10.1057/9781137497475. ISBN 978-1-137-49746-8.
- ^ http://web.princeton.edu/sites/jmadison/calendar/documents/Flyer%202015%201118%20Drakeman.pdf Archived February 1, 2016, at the Wayback Machine [bare URL PDF]
- ^ Drakeman, Donald L. (2021). The Hollow Core of Constitutional Theory: Why We Need the Framers. Cambridge University Press. doi:10.1017/9781108751001. ISBN 9781108751001. Retrieved June 23, 2024.
- ^ Drakeman, Donald L.; Drakeman, Lisa N.; Oraiopoulos, Nektarios (2022). From Breakthrough to Blockbuster: The Business of Biotechnology. Oxford University Press. p. 240. ISBN 9780195084009.
- ^ "Author Profile: Don Drakeman". The Business of Biotechnology. Retrieved June 23, 2024.
- ^ "The Business of Biotechnology". Retrieved June 23, 2024.
- ^ Religion Department Honors Theses Archived October 17, 2012, at the Wayback Machine. Dartmouth.edu. Retrieved on November 10, 2011.
- ^ Center for Private Equity and Entrepreneurship: Alumni Ventures Archived January 6, 2011, at the Wayback Machine. Mba.tuck.dartmouth.edu. Retrieved on November 10, 2011.
- ^ Harlan Fiske Stone. C250.columbia.edu. Retrieved on November 10, 2011.
- ^ a b Donald L. Drakeman > About Archived January 3, 2011, at the Wayback Machine. ACSH. Retrieved on November 10, 2011.
- ^ "Board Post To Drakeman", The Montclair Times, March 8, 1994. Accessed July 4, 2024, via Newspapers.com. "Donald L. Drakeman of Bellaire Drive has succeeded George J. Kenny as chairman of the Board of Adjustment. Mr. Kenny will continue his membership on the board."
- ^ "Mult sclerosis".
- ^ Ernst & Young – Hall Of Fame Archived October 7, 2006, at the Wayback Machine. Eoyhof.ey.com. Retrieved on November 10, 2011.
- ^ Board Roster | About Drew University | Drew University Archived December 29, 2010, at the Wayback Machine. Drew.edu (May 6, 2011). Retrieved on November 10, 2011.
- ^ Collegium Ralstonianum apud Savannenses – Home. Ralston.ac. Retrieved on November 10, 2011.
- ^ Rutgers Business School | Newark and New Brunswick. Business.rutgers.edu. Retrieved on November 10, 2011.
- ^ Landes Bioscience Journals: mAbs. Landesbioscience.com. Retrieved on November 10, 2011.
- ^ Commission on Science & Technology. State.nj.us. Retrieved on November 10, 2011.
- ^ Commission on Science & Technology | Grant Award Recipients. State.nj.us. Retrieved on November 10, 2011.
- ^ "Zymeworks Inc. — Board of Directors". Archived from the original on November 26, 2011. Retrieved 2011-11-10.
- ^ Drakeman, Donald L. "Peculiar Habits: Academic Costumes at Princeton University". Transactions of the Burgon Society. 9 4. The Burgon Society: 59–79. doi:10.4148/2475-7799.1072. ISSN 2475-7799. Retrieved August 1, 2024.
- ^ The Burgon Society: Latest News and Events Archived January 23, 2011, at the Wayback Machine. Burgon.org.uk. Retrieved on November 10, 2011.
- ^ The Burgon Society: Fellows of the Burgon Society Archived January 23, 2011, at the Wayback Machine. Burgon.org.uk. Retrieved on November 10, 2011.
External links
[edit]- Official website
- Donald L. Drakeman
- Donald Drakeman
- Don Drakeman on LinkedIn
- Donald Drakeman on X
- The Risk of De-Risking Innovation: Optimal R&D Strategies in Ambiguous Environments
- Donald Drakeman on Why we Need the Humanities
- Benchmarking biotech and pharmaceutical product development
- Renovation as innovation: is repurposing the future of drug discovery research?
- Lemons, or Squeezed for Resources? Information Symmetry and Asymmetric Resources in Biotechnology
- Biotech vs big pharma
- Agreeing to Disagree
- The Highly Useful Crisis in the Humanities
- Business Needs the Humanities to Succeed
- Why the Framers' Intentions Matter
- Donald Drakeman on Religion's Place in Public Schools
- The Usefulness of Useless Knowledge
- Donald Drakeman on the Humanities and Social Sciences
- Church, State, and Original Intent
- A Panel Discussion of Donald L. Drakeman's Church, State, and Original Intent Archived September 27, 2011, at the Wayback Machine
- Donald Drakeman on the Separation of Church and State
- The James Madison Program in American Ideals and Institutions (Princeton University)
- Ralston College
- THE BUSINESS OF BIOTECHNOLOGY
- The Future of Monoclonal Antibody Technology
- Is Corpus Linguistics Better than Flipping a Coin?
- Genmab A/S
- The Ernst & Young Entrepreneur Hall of Fame
- The University of Charleston
- The Rutgers Business School
- Judge Business School (University of Cambridge)
- Operations and Technology Management (Judge Business School)
- The Center for Citizenship & Constitutional Government
- Centre for Health Leadership & Enterprise (CCHLE)
- DLD: Research
- American venture capitalists
- American religion academics
- University of Notre Dame faculty
- Academics of the University of Cambridge
- Dartmouth College alumni
- Columbia Law School alumni
- People from Montclair, New Jersey
- Princeton University alumni
- Businesspeople in the pharmaceutical industry
- 1953 births
- Living people
- People associated with Milbank, Tweed, Hadley & McCloy
- First Amendment scholars
- American scholars of constitutional law